We issued an updated research report on Albemarle Corporation ALB on Dec 13.
Lithium Expansions to Boost Growth
Albemarle is well placed to gain from strength in the lithium business. The company is executing a number of projects to boost the global lithium derivative capacity. Its “Wave I” of lithium production capacity expansion remains on track.
The company’s Talison joint venture (JV) in Australia is expanding lithium concentrate production at the Greenbushes mine. The move is likely to double the lithium carbonate equivalent capacity at Greenbushes from 80,000 metric tons per year to more than 160,000 metric tons.
Moreover, Albemarle agreed to pay $1.15 billion for a 50% stake in a proposed JV with Mineral Resources to own and operate the Wodgina hard rock lithium mine in Australia. It will also develop an integrated lithium hydroxide operation at the resource site.
Albemarle will manage the marketing and sales of lithium hydroxide through the JV. The JV will combine world-class lithium production and marketing expertise with Mineral Resources’ leading mining capabilities along with regional presence.
Albemarle is committed to deliver incremental returns to shareholders. In February 2018, the company hiked quarterly dividend by 5% to 33.5 cents per share, marking the 24th consecutive year of dividend increase.
In August, the company initiated a new accelerated share repurchase program worth $250 million, which is expected to be complete by the end of 2018. The company has bought back roughly 4.7 million shares during the first nine months of 2018.
Albemarle has outperformed the industry in the past six months. The stock has lost 5.8% compared with the industry’s 20.3% decline.
Healthy Growth Prospects
In November, Albemarle maintained guidance for 2018. It continues to expect adjusted earnings per share (EPS) for 2018 in the band of $5.30-$5.50, marking year-over-year increase of 15-20%. The company also projects net sales for 2018 between $3.3 billion and $3.5 billion and adjusted EBITDA in the range of $990-$1,020 million.
The Zacks Consensus Estimate for Albemarle’s 2018 earnings is currently pegged at $5.43, reflecting expected year-over-year growth of 18.3%. Moreover, earnings are expected to register 12.5% growth in 2019. The company also has an expected long-term EPS growth rate of 16.3%, higher than the industry average of 12.5%.
Albemarle Corporation Price and Consensus
Albemarle Corporation Price and Consensus | Albemarle Corporation Quote
Zacks Rank & Other Stocks to Consider
Albemarle currently carries a Zacks Rank #2 (Buy).
A few other top-ranked stocks in the basic materials space are CF Industries Holdings, Inc. CF and Nexeo Solutions, Inc. NXEO, both sporting a Zacks Rank #1 (Strong Buy); along with The Mosaic Company MOS, carrying Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank stocks here.
CF Industries has an expected long-term earnings growth rate of 6%. The company’s shares have moved up 1.3% in the past year.
Nexeo Solutions has an expected long-term earnings growth rate of 30.6%. Its shares have gained 4.2% in a year’s time.
Mosaic has an expected long-term earnings growth rate of 7%. The company’s shares have rallied 24% in the past year.
More Stock News: This Is Bigger than the iPhone!
It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.
Click here for the 6 trades >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Albemarle Corporation (ALB) : Free Stock Analysis Report
CF Industries Holdings, Inc. (CF) : Free Stock Analysis Report
The Mosaic Company (MOS) : Free Stock Analysis Report
NEXEO SOLUTIONS (NXEO) : Free Stock Analysis Report
To read this article on Zacks.com click here.